Illumina Unveils New High-Throughput Sequencing Instrument at JP Morgan | GenomeWeb

This story has been updated to clarify that the cost of sequencing on the NovaSeq will be less expensive than the HiSeq X by 2018, not at launch.

SAN FRANCISCO (GenomeWeb) – Illumina launched a new high-throughput sequencing instrument, NovaSeq, at the JP Morgan Healthcare Conference here this week, which it will begin shipping in limited quantities by the end of the first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.